Finance

Lists
CRBP:NASDAQ
Corbus Pharmaceuticals Holdings Inc
၄.၃၃ US$
-၁.၈၁%
(-၀.၀၈၀) 1D
၄.၂၅ US$
-၁.၈၅% (-၀.၀၈၀)
After hours
Closed: အောက် ၁၅, GMT-၄ ၁၆:၀၀:၀၁  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRBP...
Open
၄.၄၀ US$
High
၄.၆၂ US$
Low
၄.၂၃ US$
Mkt. cap
၈.၃၇ ကုဋေ
Avg. vol.
၁.၂၃ သန်း
Volume
၆၆.၀၀
52-wk high
၂၀.၅၆ US$
52-wk low
၄.၂၃ US$
EPS
-၆.၁၇ US$
Beta
၂.၆၃
Shares outstanding
၁.၉၃ ကုဋေ
No. of employees
၃၆
Open
၄.၄၀ US$
High
၄.၆၂ US$
Low
၄.၂၃ US$
Mkt. cap
၈.၃၇ ကုဋေ
Avg. vol.
၁.၂၃ သန်း
Volume
၆၆.၀၀
52-wk high
၂၀.၅၆ US$
52-wk low
၄.၂၃ US$
EPS
-၆.၁၇ US$
Beta
၂.၆၃
Shares outstanding
၁.၉၃ ကုဋေ
No. of employees
၃၆
News stories
From web sources and news partners
About Corbus Pharmaceuticals Holdings Inc
CEO-
Employees၃၆
Founded၂၀၀၉ ဇန် ၁
Headquarters-
Sector-
Websitecorbuspharma.com
Analyst ratings
Based on 7 analysts giving stock ratings to CRBP in the past 3 months
Strong buy
Buy
7
Hold
0
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for CRBP in the last 3 months.
Highest
Current ၄.၃၃ US$
၄၈.၀၀ US$ (+၁,၀၀၈.၅၅%)
Average
၃၆.၆၇ US$ (+၇၄၆.၈၈%)
Lowest
၃၀.၀၀ US$ (+၅၉၂.၈၄%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert Driscoll
Wedbush
Buy
Reiterated
၃၀.၀၀ US$
+၅၉၂.၈%
09/15/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
၃၅.၀၀ US$
+၇၀၈.၃%
09/15/2026
Andy Hsieh
William Blair
Buy
Reiterated
-
-
09/14/2026
Oliver McCammon
LifeSci Capital
Buy
Maintained
၃၈.၀၀ US$
+၇၇၇.၆%
09/14/2026
Graig Suvannavejh
Mizuho Securities
Buy
Reiterated
၃၃.၀၀ US$
+၆၆၂.၁%
09/14/2026
Brian Abrahams
RBC Capital
Buy
Maintained
၃၆.၀၀ US$
+၇၃၁.၄%
08/12/2026
Jeff Jones
Oppenheimer
Buy
Reiterated
၄၈.၀၀ US$
+၁,၀၀၈.၅%
08/07/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
၄၈.၀၀ US$
+၁,၀၀၈.၅%
08/07/2026
Paul Jeng
Guggenheim
Buy
Maintained
၄၅.၀၀ US$
+၉၃၉.၃%
06/02/2026
Unknown Analyst
Wedbush
Buy
Reiterated
၃၈.၀၀ US$
+၇၇၇.၆%
05/13/2026
Maury Raycroft
Jefferies
Buy
Maintained
၃၃.၀၀ US$
+၆၆၂.၁%
05/12/2026
Unknown Analyst
B. Riley Securities
Buy
Reiterated
၂၈.၀၀ US$
+၅၄၆.၇%
04/10/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
-
-
-
-
Cost of goods sold
၂.၀၉ ကုဋေ
၁.၈၄ ကုဋေ
၁.၉၈ ကုဋေ
၃.၁၂ ကုဋေ
Cost of revenue
၂.၀၉ ကုဋေ
၁.၈၄ ကုဋေ
၁.၉၈ ကုဋေ
၃.၁၂ ကုဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃.၅၆ သန်း
၃.၅၆ သန်း
၄.၄၈ သန်း
၅.၀၂ သန်း
Operating expense
၃.၅၆ သန်း
၃.၅၆ သန်း
၄.၄၈ သန်း
၅.၀၂ သန်း
Total operating expenses
၂.၄၄ ကုဋေ
၂.၂၀ ကုဋေ
၂.၄၃ ကုဋေ
၃.၆၂ ကုဋေ
Operating income
-၂.၄၄ ကုဋေ
-၂.၂၀ ကုဋေ
-၂.၄၃ ကုဋေ
-၃.၆၂ ကုဋေ
Other non operating income
-၅.၀၀ သောင်း
-၁.၁၀ သန်း
-၆.၇၀ သောင်း
-၁.၁၀ သောင်း
EBT including unusual items
-၂.၃၃ ကုဋေ
-၂.၀၆ ကုဋေ
-၂.၃၀ ကုဋေ
-၃.၅၀ ကုဋေ
EBT excluding unusual items
-၂.၃၃ ကုဋေ
-၂.၁၇ ကုဋေ
-၂.၃၀ ကုဋေ
-၃.၅၀ ကုဋေ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-၂.၃၃ ကုဋေ
-၂.၀၆ ကုဋေ
-၂.၃၀ ကုဋေ
-၃.၅၀ ကုဋေ
Net profit margin
-
-
-
-
Earnings per share
-၁.၉၀
-၁.၂၅
-၁.၂၃
-၁.၈၁
Interest and investment income
၁.၁၂ သန်း
၁.၄၁ သန်း
၁.၄၀ သန်း
၁.၁၆ သန်း
Interest expense
-
-
-
-
Net interest expenses
၁.၁၂ သန်း
၁.၄၁ သန်း
၁.၄၀ သန်း
၁.၁၆ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၂.၄၄ ကုဋေ
-၂.၁၉ ကုဋေ
-၂.၄၃ ကုဋေ
-၃.၆၁ ကုဋေ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google အက်ပ်များ